« FDA Approvals - AGA Medical Corporation Receives FDA and CE Mark Approvals for | Main | FDA Clears for Marketing First Rapid Test to Screen for »

Oscient Pharmaceuticals Receives Expected NASDAQ Notice of Non-Compliance; Company Intends


Oscient Pharmaceuticals Receives Expected NASDAQ Notice of Non-Compliance; Company Intends to Request Hearing (FinanzNachrichten)
Oscient Pharmaceuticals ( Nachrichten ) Corporation (Nasdaq: OSCI) has received the expected notification from the NASDAQ Listing Qualifications Department that the Company has not regained compliance since being notified on August 17, 2007 that the market value of its common shares was below the $50 million requirement for continued listing on The NASDAQ Global Market according to Marketplace ...

Governance, Risk and Compliance IT Solutions Provider EnCrisp LLC Recognized as Certified Virginia Minority Business ... (PRWeb)
EnCrisp LLC, a global leader in designing and implementing leading-edge Governance, Risk and Compliance (GRC) solutions, today announced that it has been recognized by the Commonwealth of Virginia as an Emerging Technology Enterprise certified by the Virginia Department of Minority Business Enterprises/Small Business Enterprise (MBE/SBE). (PRWeb Sep 20, 2007)

FDA warns Procter and Gamble on hand sanitizer marketing (News-Medical-Net)
The U.S. Food and Drug Administration (FDA) has sent a warning letter to Procter & Gamble for making unlawful claims about its Vicks Early Defense Foaming Hand Sanitizer (Early Defense) product.
 

©2006 FDA-News.com. All rights reserved.